Citation 41208

PROTAIS,P: CORTES,D: PONS,JL: LOPEZ,S: VILLAVERDE,MC: CASTEDO,L:. (1992). DISPLACEMENT ACTIVITY OF SOME NATURAL CULARINE ALKALOIDS AT STRIATAL 3H-SCH 23 390 AND 3H-RACLOPRIDE BINDING SITES.. 48(1)

Citation Details

Title	DISPLACEMENT ACTIVITY OF SOME NATURAL CULARINE ALKALOIDS AT STRIATAL 3H-SCH 23 390 AND 3H-RACLOPRIDE BINDING SITES.
Authors	PROTAIS,P: CORTES,D: PONS,JL: LOPEZ,S: VILLAVERDE,MC: CASTEDO,L:
Year	1992
Volume	48
Issue	1

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (4)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	PMR SPECTRUM REPORTED	CRASSIFOLINE,ISO:	None
2	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSIFOLINE,ISO:	ACTIVE
3	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSIFOLINE,ISO:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE	ACTIVE
2	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DOPAMINE	ACTIVE

Guatteria ouregou (ANNONACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	GOUREGINE	None
2	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GOUREGINE	EQUIVOCAL
3	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GOUREGINE	INACTIVE

Sarcocapnos crassifolia (PAPAVERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	CULARIDINE,(+):	None
2	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CULARIDINE,(+):	ACTIVE
3	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CULARIDINE,(+):	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	CELTISINE,(+):	None
5	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CELTISINE,(+):	ACTIVE
6	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CELTISINE,(+):	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	BREGOGANINE,(+):	None
8	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BREGOGANINE,(+):	ACTIVE
9	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BREGOGANINE,(+):	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	SARCOCAPNIDINE,(+):	None
11	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SARCOCAPNIDINE,(+):	EQUIVOCAL
12	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SARCOCAPNIDINE,(+):	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTED	CLAVICULINE,(+):	None
14	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CLAVICULINE,(+):	ACTIVE
15	DOPAMINE RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CLAVICULINE,(+):	ACTIVE

Show SPARQL Queries (1)